Enhancing Cognitive Function
Keeping your memory in tip top shapeMay 2000
By Ivy Greenwell
"Viagra" for the brain
First introduced 22 years ago in Hungary for the treatment of vascular dementia-a disorder resulting from insufficient blood flow to the brain tissue-vinpocetine has gradually gained popularity as a European "smart drug." Recently it has become available in the United States. It is a promising neuroprotective supplement and cognitive booster.
It is interesting that vinpocetine has a similar mechanism of action as Viagra. Both are known to be effective phosphodiesterase inhibitors. That is, they work to enhance blood flow by inhibiting an enzyme in the phosphodiesterase family. Not surprisingly, the main benefit of vinpocetine is an improvement in cerebral blood flow. More blood reaching the brain cells means better oxygenation, nutrition and waste removal-all of which adds up to more youthful brain function.
Vinpocetine has also been found to improve the transport of glucose (both uptake and release) across the blood-brain barrier. Low cellular energy production is perhaps the primary factor underlying all aging-related brain degeneration. In addition, vinpocetine has been shown to increase the firing rate of certain types of noradrenergic neurons, which could explain one mechanism of its action as a cognitive booster.
The enhancement of blood flow and energy production means that vinpocetine is particularly recommended for people whose cognitive dysfunction stems chiefly from insufficient blood flow to the brain. Vinpocetine also shows promise in helping prevent damage to vision, especially dry macular degeneration. Vinpocetine likewise appears to improve blood flow to the inner ear, thus protecting hearing. Interestingly, vinpocetine has likewise been found to counteract space motion sickness. It can also partly protect against the damage resulting from excess glutamate and other excitotoxins.
A new neuroprotective property of vinpocetine has just been discovered: it can lower the production of inflammatory cytokines. Together with other phosphodiesterase inhibitors, vinpocetine has been shown to lower the production by the microglia of a major inflammatory compound known as tumor necrosis factor-alpha (TNF-alpha).
Some alternative clinicians believe that if we could truly control inflammation, we could prevent Alzheimer's disease. This view is based on the proven effectiveness of anti-inflammatories such as ibuprofen in lowering the risk of Alzheimer's disease. The problem with commonly used pharmaceutical anti-inflammatories is their side effects. Vinpocetine and other natural anti-inflammatories (fish oil, vitamin E, estrogens, many antioxidants including bilberry extract and green tea catechins) appear to be a nontoxic alternative.
Vinpocetine is an alkaloid, in the same family as caffeine and nicotine, both known to be very effective cognitive enhancers. Nicotine increases the release of acetylcholine and dopamine, and improves both short-term recall and long-term potentiation. But while caffeine and nicotine each have well-known drawbacks, vinpocetine appears to be safe and non-addictive. It would not be surprising if vinpocetine shared nicotine's protective benefits against Alzheimer's disease and Parkinson's disease, without the problem of addiction. An interesting side benefit of vinpocetine is that it has also been found to protect against both gastric and cerebral damage induced by alcohol, against kidney problems caused by renal vasoconstriction, and against retinal damage caused by the hepatitis B virus.
Hormone of memory and good cheer
Pregnenolone was discovered during the 1930s and was extensively studied at first, particularly in connection with job performance and as a therapy for arthritis. Then it faded into oblivion as other hormones, notably synthetic forms of cortisone, became more trendy, not to mention lucrative for the drug industry.
Now we are witnessing a revival of interest in pregnenolone-after 60 years, it's gaining popularity alongside DHEA. Pregnenolone functions largely as a pro-hormone. Produced primarily in the adrenals, it is also the primary precursor of all the steroid hormones, the first hormone to be formed from cholesterol, the raw material for all steroids.
The levels of pregnenolone go down with aging. By the time we are 75, we have only 40% of the pregnenolone we had when we were 35. Besides aging, stress, disease, hypothyroidism, exposure to toxins and depression all result in low pregnenolone levels. Patients suffering from depression have been found to have pregnenolone levels less than half those found in nondepressed persons. These decreased levels of pregnenolone have been found in both unipolar and bipolar depression (the manic-depressive disorder). In job-performance studies, subjects reported better mood when taking pregnenolone. Like estrogen and DHEA, pregnenolone seems to have a pleasantly stimulatory effect on the brain, making one feel sharp without that wired, jittery feeling that may come from too much caffeine, for instance.
While many people know that DHEA and its sulfate, DHEA-S, are very abundant in the brain, few know that the brain levels of pregnenolone and pregnenolone sulfate are 10 times as high as those of DHEA. Pregnenolone could be called our primary neurosteroid. It is produced not only in the adrenals, but also in the brain-a finding first reported by the famous French steroid researcher, Dr. Etienne-Emile Baulieu. The peripheral nervous system can also manufacture pregnenolone, possibly for the purpose of maintaining the myelin sheath.
Pregnenolone is somewhat like ginseng. It improves energy, endurance and ability to cope with stress. Studies using factory workers, college students and airline pilots all found that pregnenolone effectively counteracts fatigue. When you are under stress, pregnenolone gives you an extra edge. When you are relaxed, however, you tend not to feel much difference. This may be particularly true of younger people. The elderly, who are more seriously deficient, seem to appreciate pregnenolone's extra energy boost more keenly.
In the 1940s, it was established that pregnenolone facilitates learning and helps us perform any task in which memory is involved. But pregnenolone's chief claim to fame is the fact that this pre-hormone has been found to be the most effective memory booster yet discovered in animal studies. It has been shown to increase the release of acetylcholine and to modulate NMDA (aspartate/glutamate) receptors in a way that suggests that pregnenolone stimulates central cholinergic communication. It also seems to modulate enzyme activity, calcium-ion flow through cell membranes, protein turnover and other complex reactions involved in memory function. Together with DHEA, pregnenolone also synchronizes the firing of the neurons. A decline in pregnenolone thus makes all mental function more difficult.
There is some anecdotal evidence suggesting that pregnenolone may be especially effective in elderly women as a restorer of energy and mental clarity, and as an antidepressant.
Even a small amount of supplemental pregnenolone may affect the quality of sleep. Most studies find that pregnenolone, like DHEA, increases the amount of REM sleep, which appears to be play a role in the formation of memory.
Like progesterone, pregnenolone is also important for repairing the brain and the spinal cord in case of injury. Pregnenolone is a precursor to progesterone in the body.
Caution: Men diagnosed with prostate cancer are advised to avoid pregnenolone because of the possibility of conversion into androgens.
Alpha lipoic acid has
emerged as a new
star in brain boosting,
in addition to
such as acetyl-l-carnitine
There are a variety of other supplements that may enhance your brain longevity program. Among these is alpha lipoic acid, which is both an antioxidant and a metabolic enhancer and has emerged as a new star. It is joined by neuroprotective energy-enhancers: acetyl-L-carnitine and coQ10.
The nervous system also needs the benefits of antioxidants and anti-inflammatories such as vitamin E, shown not only to protect the membranes but also to restore damaged neurotransmitter receptors, and fish oil. After all, fish eating has been documented to correlate with a dramatic lower risk of Alzheimer's disease. Neuroprotective regimens should also include the catechins in green tea extract, and/or the proanthocyanidins in grape seed extract and similar compounds in bilberry extract.
High-potency ginkgo is also highly recommended. In addition to being a documented cognitive enhancer, it has recently been found to extend life span in rats. Improvement in Alzheimer's disease patients has been noted with doses of 240 mg and higher.
Getting enough sleep and rest is extremely important. We must also take measures to reduce cortisol, which has neurotoxic effects. Meditation and stress reduction are effective measures, as are supplements such as DHEA, pregnenolone, and KH3. Chronic stress, today the daily condition of millions, causes an increase in free radicals (both oxygen and nitric oxide-based) and inflammatory cytokines. Fortunately most of the compounds mentioned here are both excellent antioxidants and anti-inflammatories; vitamin E and green tea catechins are stellar examples. Finally, vitamin C is extremely important for the brain. Besides functioning as an antioxidant, it also enhances the synthesis of key neurotransmitters, including acetylcholine and dopamine. Niacin (B3) also helps manufacture neurotransmitters, including the calming GABA. Interestingly, yet another B vitamin, thiamin (vitamin B1) has turned out to be a potent antioxidant, helping other antioxidants such as vitamin E to destroy free radicals.
Remember: unless you slow down your aging, aging is going to slow you down. It will make you increasingly physically and mentally disabled, sluggish, forgetful and depressed, ultimately making life not seem worth living. Fortunately, you can fight back with lifestyle, the right diet and the right supplements.
Aleppo G et al. Chronic glyceryl-phosphorylcholine increases inositol phosphate formation in brain slices and neuronal cultures. Pharmacol Toxicol 1994; 74:95-100.
Amenta F et al. Cholinergic neurotransmission in the hippocampus of aged rats: influence of glyceryl-phosphorylcholine treatment. Ann NY Acad Sci 1993: 695:311-3.
Borghese CM et al. Phosphatidyl serine increases hippocampal synaptic efficacy. Brain Res 1993; 31:697-700.
Bronzetti E et al. Effects of ipsilateral lesioning of the nucleus basalis magnocellularis and of glyceryl-phosphorylcholine treatment on acetyltransferase and acetylcholinesterase in the rat front-parietal cortex. Neurosci Lett 1993; 164:47-50.
Ceda CP et al. Glyceryl-phosphorylcholine administration increases the growth hormone responses to GHRH of young and elderly subjects. Horm Metabolism Res 1992; 24:119-21.
Ceda GP et al. Glyceryl-phosphorylcholine administration increases the growth hormone response to GHRH in young and elderly subjects. Horm Metabolism Res 1992; 24: 119-21.
Cermak JM et al. Prenatal availability of choline alters the development of acetylcholinesterase in the rat hippocampus. Dev Neurosci 1999; 21:94-104.
Chalimoniuk M, Strosznaider JB. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Mol Chem Neuropathol 1998; 35:77-95.
Coccoli C. Glyceryl-phosphorylcholine and glycerophosphorylethanolamine: their preparation and uses (Manufacturer's pamphlet)
Cohen SA et al. Age-related alteration in NMDA-receptor properties in the mouse forebrain: partial restoration by phosphatidyl serine treatment. Brain Res 1992; 584:174-80.
Cooney C and Lawren B. Methyl Magic. Andrews McMeel Publishing, 1999; quotation about choline and membrane chemical signaling, p. 132.
Coutcher JB et al. Dietary choline supplementation increases the density of nicotine binding sites in rat brain. J Pharmacol Exp Ther 1992; 262:1128-32.
Crook T et al. Effects of phosphatidyl serine in age-associated memory impairment. Neurology 1991; 4:644-9.
Crook T et al. Effects of phosphatidyl serine in Alzheimer's disease. Psychopharmacol Bull 1992; 28:61-66.
Di Perri R et al. A multicentre trial to evaluate the efficacy and tolerability of glyceryl-phosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Int Med Res 1991; 19:330-41
Dolby V. Pregnenolone. Keats Publishing, 1998.
Fallbrook A et al. Phosphatidyl choline and phosphatidyl ethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Res 1999; 834:207-10.
Flood JF et al. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 1992; 89:1567-71.
Fujii S et al. Acute and chronic nicotine exposure differentially facilitate the induction of LTP.Brain Res 1999; 846:137-143.
Funfgeld EW et al. Double-blind study with phosphatidyl serine in Parkinsonian patients with senile dementia of Alzheimer's type. Progesterone Clin Biol Res 1989; 317:1235-46.
Gatti G et al. A comparative study of free plasma choline levels following intramuscular administration of glyceryl-phosphorylcholine and citicoline in normal volunteers. Int J Clin Pharmacol Ther Toxicol 1992; 30:331-5.
Gimenez R et al. Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats. Neurosci Lett 1999; 273:163-6.
Gulyas B et al. Cerebral uptake and metabolism of vinpocetine in monkeys: PET studies. Orv Hetil 1999;140:1687-91.
Hogervorst E et al. Caffeine improves cognitive performance after strenuous physical exercise. Int J Sports Med 1999; 20:354-61.
Jacob RA et al. Folate nutriture alters choline status of women and men fed low choline diets. J Nutr 1999; 129:712-7.
Khalsa DS. Brain Longevity. Warner Books, 1997.
Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999; 4:144-61.
Koyama Y et al. How does the distension of urinary bladder cause arousal? Psychiatry Clin Neurosci 1998; 52:142-5.
Lillestl IK et al. Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery. Scand J Clin Lab Invest 1998; 58:625-34.
Martinez M, Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem 1998; 71:2528-33.
Meck WH et al. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci 1989; 103:1234-41.
Meier-Ruge WA, Bertoni-Freddari C. Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease. Gerontology 1999; 45:289-97.
Molnar P et al. The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognitive enhancers. Neurobiology 1994; 2:225-66.
Monteleone P et al. Blunting by chronic phosphatidyl serine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol 1992; 42:385-8.
"Over 75 mental decline steeper than expected." Reuters Health, November 3, 1999.
Packer L and Colman C. The Antioxidant Miracle. John Wiley and Son, 1999.
Pallares M et al. The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory. Neuroscience 1998; 87:551-8.
Pan Y et al. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med 1999; 221:118-25.
Parnetti L et al. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type. Drugs & Aging, 1993; 3:159-64.
Pyapali GK et al. Prenatal dietary choline supplementation decreases the threshold for induction of long-term potentiation in young adult rats. J Neurophysiol 1998; 79:1790-96.
Regelson W, Colman C. The Superhormone Promise. Simon and Schuster, 1996.
Sangiorgi GB et al. Glyceryl-phosphorylcholine in the mental recovery of cerebral ischemic attacks. Ann NY Acad Sci 1994; 717:253-69.
Schettini G et al. Molecular mechanisms for mediating the effects of glyceryl-phosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats. Pharmacol Biochem Behav 1992; 43:139-51.
Sicurella L et al. Evoked visual potentials modifications in subjects treated with glyceryl-phosphorylcholine. Manufacturer's Pamphlet.
Szakall S et al. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study. J Neuroimaging 1998; 8:197-204.
Szutowicz A et al. Key role of acetyl-CoA in cytoplasm of nerve terminals in disturbances of acetylcholine metabolism in the brain. Folia Neuropathol 1997; 35:241-3.
Vallee M et al. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 1997; 94:14865-70.
Warburton DM. Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology 1995; 119:66-70.
Wecker L. Influence of dietary choline availability and neuronal demand on acetylcholine synthesis by rat brain. J Neurochem 1988; 51:497-504.
Wecker L. Neurochemical effects of choline supplementation. Can J Physiol Pharmacol 1986; 64:329-33.
Weinman B et al. Studies on wound healing: effects of calcium D-pantothenate on the migration, proliferation and protein synthesis of human dermal fibroblasts in culture. Internat J Vitamin Nutr Res 1999; 69:113-19.
Yoshikawa M et al. Effects of phosphodiesterase inhibitors on cytokine production by microglia. Mult Scler 1999; 5:126-33.